This inventor holds 2 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1991-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ashiya, JP (1991)
- Hyogo-ken, JP (1998)
Company Filing History:
Years Active: 1991-1998
Title: Hitoshi Kubota: Innovator in Pharmaceutical Chemistry
Introduction
Hitoshi Kubota is a notable inventor based in Ashiya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Kubota's work focuses on compounds with antioxidative properties and processes for synthesizing complex chemical derivatives.
Latest Patents
Kubota's latest patents include a phenol compound that exhibits antioxidative activity. This compound is represented by a specific formula, where various substituents can be modified to enhance its properties. Additionally, he has developed a process for preparing optically active 2-oxoimidazolidine derivatives, which are crucial in the synthesis of various pharmaceutical agents. This process involves specific configurations that are essential for the desired biological activity.
Career Highlights
Hitoshi Kubota is currently associated with Tanabe Seiyaku Company, Limited, a prominent player in the pharmaceutical industry. His work at the company has allowed him to focus on innovative research and development, contributing to advancements in drug formulation and synthesis.
Collaborations
Throughout his career, Kubota has collaborated with esteemed colleagues such as Toshikazu Suzuki and Hiroshi Ohmizu. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Hitoshi Kubota's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile